Copyright
©The Author(s) 2025.
World J Clin Oncol. Jun 24, 2025; 16(6): 106629
Published online Jun 24, 2025. doi: 10.5306/wjco.v16.i6.106629
Published online Jun 24, 2025. doi: 10.5306/wjco.v16.i6.106629
Table 3 Characteristics of the Oslo, Fong, and Eastern Cooperative Oncology Group scoring systems
Score | Component | Scoring/criteria | Cutoff | Clinical interpretation |
Oslo | Tumor size | > 5.5 cm = 1 point | ≥ 2 points | Higher recurrence risk post-LT |
CEA level | > 80 ng/mL = 1 point | |||
Time from primary to LT | < 2 years = 1 point | |||
Response to chemotherapy | < 10% shrinkage = 1 point | |||
Fong | Nodal status of primary | Positive = 1 point | ≥ 3 points | Worse prognosis post-resection |
Disease-free interval | < 12 months = 1 point | |||
Number of liver metastases | > 1 = 1 point | |||
CEA level | > 200 ng/mL = 1 point | |||
Largest tumor | > 5 cm = 1 point | |||
ECOG | Performance status | 0 = fully active; 1 = symptomatic but completely ambulatory; 2 = symptomatic, < 50% in bed during the day; 3 = symptomatic, > 50% in bed, but not bedbound; 4 = bedridden | ≥ 2 = ineligible | Stratifies fitness for treatment or surgery |
- Citation: Cigrovski Berkovic M, Mrzljak A, Melandro F, Lai Q. Inclusion criteria for liver transplantation in patients with colorectal liver metastases: How to make the best selection? World J Clin Oncol 2025; 16(6): 106629
- URL: https://www.wjgnet.com/2218-4333/full/v16/i6/106629.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i6.106629